Array BioPharma Inc: Highlights
Financial data in U.S. dollars
| Financial Highlights |
|---|
| Sales |
29.08 Mil |
| Income |
-102.94 Mil |
| Net Profit Margin |
-354.00% |
| Return on Equity |
NA |
| Debt/Equity Ratio |
NA |
|
| Revenue/Share |
0.60 |
| Earnings/Share |
-2.13 |
| Book Value/Share |
-1.93 |
| Dividend Rate |
0.00 |
| Payout Ratio |
NA |
|
| Revenue - Quarterly Results (in Millions) |
|---|
| | FY (06/10) | FY (06/09) | FY (06/08) |
|---|
| 1st Qtr | 7.9 | 5.7 | 6.6 |
| 2nd Qtr | 9.6 | 7.7 | 8.4 |
| 3rd Qtr | NA | 6.0 | 7.7 |
| 4th Qtr | NA | 5.5 | 6.1 |
| Total | 17.5 | 25.0 | 28.8 |
| Earnings Per Share - Quarterly Results |
|---|
| | FY (06/10) | FY (06/09) | FY (06/08) |
|---|
| 1st Qtr | -$0.52 | -$0.71 | -$0.40 |
| 2nd Qtr | -$0.44 | -$0.79 | -$0.43 |
| 3rd Qtr | NA | -$0.62 | -$0.51 |
| 4th Qtr | NA | -$0.55 | -$0.68 |
| Total | -$0.96 | -$2.67 | -$2.02 |
| Qtr. over Qtr. EPS Growth Rate |
| FY (06/10) | FY (06/09) | FY (06/08) |
|---|
| 1st Qtr | 5% | -4% | --- |
| 2nd Qtr | 15% | -11% | -8% |
| 3rd Qtr | NA | 22% | -19% |
| 4th Qtr | NA | 11% | -33% |
| Yr. over Yr. EPS Growth Rate |
| FY (06/10) | FY (06/09) |
|---|
| 1st Qtr | 27% | -77% |
| 2nd Qtr | 44% | -84% |
| 3rd Qtr | NA | -22% |
| 4th Qtr | NA | 19% |
advertisement
Recent News